의료용 테이프 및 붕대 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2023-2030년)

Medical Tapes And Bandages Market Growth & Trends:

The global medical tapes and bandages market size is anticipated to reach USD 12.22 billion by 2030, according to a new report by Grand View Research, Inc.. The market is projected to grow at a CAGR of 3.42% from 2023 to 2030. Technological advancements, rising wound care awareness, novel product launches, rising number of road accidents, and rising incidence of hospital-acquired infections (HAIs) are the key driving factors for the market growth.

Medical tapes and bandages are becoming more effective and convenient due to constant advances in adhesive technology and materials. These developments enhance patient outcomes and boost market expansion. For instance, in February 2023, researchers from Northwestern University created the first-ever tiny, elastic bandage that delivers electrotherapy.right to the wound site to speed up healing. This transient electronic bandage accelerates recovery by 30%. In addition, the bandage constantly tracks the course of recovery until it dissolves completely into the human body once it is no longer required. For individuals with diabetes, whose ulcers can result in several problems, including amputation of limbs or even death, the novel device may be a valuable tool. Thus, due to such factors, the market is expected to grow in the near future.

Medical Tapes And Bandages Market Report Highlights:

• In terms of product, the medical bandages segment dominated the market in 2022 with the largest revenue share of 57.92%. The increasing number of road accidents and rising incidence of healthcare-associated infections across the globe is the major factor propelling the segment growth
• In terms of application, the surgical wound segment dominated the market in 2022 with the largest revenue share of 58.14%. The swiftly rising prevalence of chronic diseases including cancer and diabetes is creating a demand for medical bandages and tapes
• In terms of end-use, the hospitals segment held the largest revenue share of 28.00% in 2022. The increasing number of hospitals in developing countries is expected to propel the segment growth
• Based on region, North America dominated the market with a revenue share of 45.46% in 2022. The market is competitive, with both established companies and emerging players striving to capture market share through product innovation, mergers, acquisitions, and partnerships. Thus, the presence of key players in this region enhances the industry growth

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Product
  • 1.1.2. Application
  • 1.1.3. End-use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End-use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Medical Tapes and Bandages Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market driver analysis
    • 3.4.1.1. Global increase in prevalence of chronic diseases
    • 3.4.1.2. Increasing mergers and acquisitions among the industry's key players
  • 3.4.2. Market restraint analysis
    • 3.4.2.1. Stringent manufacturing policies
• 3.5. Medical Tapes and Bandages Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape
  • 3.5.3. Major Deals & Strategic Alliances Analysis
  • 3.5.4. Market Entry Strategies

Chapter 4. Medical Tapes and Bandages Market: Product Estimates & Trend Analysis

• 4.1. Definitions and Scope
  • 4.1.1. Medical Tapes
  • 4.1.2. Medical Bandages
• 4.2. Product Market Share, 2022 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Medical Tapes and Bandages Market by Product Outlook
• 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5.1. Medical Tapes
    • 4.5.1.1. Medical tapes market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.1.1. Fabric Tapes
    • 4.5.1.1.1.1. Fabric tapes market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.1.1.1.1. Acetate
    • 4.5.1.1.1.1.1.1. Acetate market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.1.1.1.2. Viscose
    • 4.5.1.1.1.1.2.1. Viscose market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.1.1.1.3. Cotton
    • 4.5.1.1.1.1.3.1. Cotton market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.1.1.1.4. Silk
    • 4.5.1.1.1.1.4.1. Silk market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.1.1.1.5. Polyester
    • 4.5.1.1.1.1.5.1. Polyester market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.1.1.1.6. Other Fabric Tapes
    • 4.5.1.1.1.1.6.1. Other fabric tapes tapes market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.1.2. Paper Tapes
    • 4.5.1.1.2.1. Paper tapes market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.1.3. Plastic Tapes
    • 4.5.1.1.3.1. Plastic tapes market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.1.3.1.1. Polypropylene
    • 4.5.1.1.3.1.1.1. Polypropylene market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.1.3.1.2. Other Plastic Tapes
    • 4.5.1.1.3.2. Other plastic tapes market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.1.1.4. Other Tapes
    • 4.5.1.1.4.1. Other tapes market estimates and forecast 2018 to 2030 (USD Million)
  • 4.5.2. Medical Bandages
    • 4.5.2.1. Medical bandages market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.1.1. Muslin Bandage Rolls
    • 4.5.2.1.1.1. Muslin bandage rolls market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.1.2. Elastic Bandage Rolls
    • 4.5.2.1.2.1. Elastic bandage rolls market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.1.3. Triangular Bandage Rolls
    • 4.5.2.1.3.1. Triangular bandage rolls market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.1.4. Orthopedic Bandage Rolls
    • 4.5.2.1.4.1. Orthopedic bandage rolls market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.1.5. Elastic Plaster Bandages
    • 4.5.2.1.5.1. Elastic plaster bandages market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2.1.6. Other Bandages
    • 4.5.2.1.6.1. Other bandages market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Medical Tapes and Bandages Market: Application Estimates & Trend Analysis

• 5.1. Definitions and Scope
  • 5.1.1. Surgical Wound
  • 5.1.2. Traumatic Wound
  • 5.1.3. Ulcer
  • 5.1.4. Sports Injury
  • 5.1.5. Burn Injury
  • 5.1.6. Other Injury
• 5.2. Application Market Share, 2022 & 2030
• 5.3. Segment Dashboard
• 5.4. Medical Tapes and Bandages Market by Application Outlook
• 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5.1. Surgical Wound
    • 5.5.1.1. Surgical wound market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.2. Traumatic Wound
    • 5.5.2.1. Traumatic wound market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.3. Ulcer
    • 5.5.3.1. Ulcer market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.4. Sports Injury
    • 5.5.4.1. Sports injury market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.5. Burn Injury
    • 5.5.5.1. Burn injury market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5.6. Other Injury
    • 5.5.6.1. Other injury market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Medical Tapes and Bandages Market: End-use Estimates & Trend Analysis

• 6.1. Definitions and Scope
  • 6.1.1. Hospitals
  • 6.1.2. Ambulatory Surgery Centres
  • 6.1.3. Clinics
  • 6.1.4. Retail
  • 6.1.5. Others
• 6.2. End-use Market Share, 2022 & 2030
• 6.3. Segment Dashboard
• 6.4. Medical Tapes and Bandages Market by End-use Outlook
• 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5.1. Hospitals
    • 6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.2. Ambulatory Surgery Centers
    • 6.5.2.1. Ambulatory surgery centres market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.3. Clinics
    • 6.5.3.1. Clinics market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.4. Retail
    • 6.5.4.1. Retail market estimates and forecast 2018 to 2030 (USD Million)
  • 6.5.5. Others
    • 6.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Medical Tapes and Bandages Market: Regional Estimates & Trend Analysis

• 7.1. Regional market share analysis, 2022 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Global Regional Market Snapshot
• 7.4. Regional Market Share and Leading Players, 2022
  • 7.4.1. North America
  • 7.4.2. Europe
  • 7.4.3. Asia Pacific
  • 7.4.4. Latin America
  • 7.4.5. Middle East and Africa
• 7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
• 7.6. North America
  • 7.6.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
  • 7.6.2. U.S.
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. U.S. market estimates and forecasts, 2018-2030
  • 7.6.3. Canada
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Canada market estimates and forecasts, 2018-2030
• 7.7. Europe
  • 7.7.1. UK
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Competitive Scenario
    • 7.7.1.3. Regulatory framework
    • 7.7.1.4. Reimbursement scenario
    • 7.7.1.5. UK market estimates and forecasts, 2018-2030
  • 7.7.2. Germany
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Germany market estimates and forecasts, 2018-2030
  • 7.7.3. France
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. France market estimates and forecasts, 2018-2030
  • 7.7.4. Italy
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. Italy market estimates and forecasts, 2018-2030
  • 7.7.5. Spain
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. Spain market estimates and forecasts, 2018-2030
  • 7.7.6. Denmark
    • 7.7.6.1. Key country dynamics
    • 7.7.6.2. Competitive Scenario
    • 7.7.6.3. Regulatory framework
    • 7.7.6.4. Reimbursement scenario
    • 7.7.6.5. Denmark market estimates and forecasts, 2018-2030
  • 7.7.7. Sweden
    • 7.7.7.1. Key country dynamics
    • 7.7.7.2. Competitive Scenario
    • 7.7.7.3. Regulatory framework
    • 7.7.7.4. Reimbursement scenario
    • 7.7.7.5. Sweden market estimates and forecasts, 2018-2030
  • 7.7.8. Norway
    • 7.7.8.1. Key country dynamics
    • 7.7.8.2. Competitive Scenario
    • 7.7.8.3. Regulatory framework
    • 7.7.8.4. Reimbursement scenario
    • 7.7.8.5. Norway market estimates and forecasts, 2018-2030
• 7.8. Asia Pacific
  • 7.8.1. Japan
    • 7.8.1.1. Key country dynamics
    • 7.8.1.2. Competitive Scenario
    • 7.8.1.3. Regulatory framework
    • 7.8.1.4. Reimbursement scenario
    • 7.8.1.5. Japan market estimates and forecasts, 2018-2030
  • 7.8.2. India
    • 7.8.2.1. Key country dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. India market estimates and forecasts, 2018-2030
  • 7.8.3. China
    • 7.8.3.1. Key country dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. China market estimates and forecasts, 2018-2030
  • 7.8.4. South Korea
    • 7.8.4.1. Key country dynamics
    • 7.8.4.2. Competitive Scenario
    • 7.8.4.3. Regulatory framework
    • 7.8.4.4. Reimbursement scenario
    • 7.8.4.5. South Korea market estimates and forecasts, 2018-2030
  • 7.8.5. Australia
    • 7.8.5.1. Key country dynamics
    • 7.8.5.2. Competitive Scenario
    • 7.8.5.3. Regulatory framework
    • 7.8.5.4. Reimbursement scenario
    • 7.8.5.5. Australia market estimates and forecasts, 2018-2030
  • 7.8.6. Thailand
    • 7.8.6.1. Key country dynamics
    • 7.8.6.2. Competitive Scenario
    • 7.8.6.3. Regulatory framework
    • 7.8.6.4. Reimbursement scenario
    • 7.8.6.5. Thailand market estimates and forecasts, 2018-2030
• 7.9. Latin America
  • 7.9.1. Brazil
    • 7.9.1.1. Key country dynamics
    • 7.9.1.2. Competitive Scenario
    • 7.9.1.3. Regulatory framework
    • 7.9.1.4. Reimbursement scenario
    • 7.9.1.5. Brazil market estimates and forecasts, 2018-2030
  • 7.9.2. Mexico
    • 7.9.2.1. Key country dynamics
    • 7.9.2.2. Competitive Scenario
    • 7.9.2.3. Regulatory framework
    • 7.9.2.4. Reimbursement scenario
    • 7.9.2.5. Mexico market estimates and forecasts, 2018-2030
  • 7.9.3. Argentina
    • 7.9.3.1. Key country dynamics
    • 7.9.3.2. Competitive Scenario
    • 7.9.3.3. Regulatory framework
    • 7.9.3.4. Reimbursement scenario
    • 7.9.3.5. Argentina market estimates and forecasts, 2018-2030
• 7.10. MEA
  • 7.10.1. South Africa
    • 7.10.1.1. Key country dynamics
    • 7.10.1.2. Competitive Scenario
    • 7.10.1.3. Regulatory framework
    • 7.10.1.4. Reimbursement scenario
    • 7.10.1.5. South Africa market estimates and forecasts, 2018-2030
  • 7.10.2. Saudi Arabia
    • 7.10.2.1. Key country dynamics
    • 7.10.2.2. Competitive Scenario
    • 7.10.2.3. Regulatory framework
    • 7.10.2.4. Reimbursement scenario
    • 7.10.2.5. Saudi Arabia market estimates and forecasts, 2018-2030
  • 7.10.3. UAE
    • 7.10.3.1. Key country dynamics
    • 7.10.3.2. Competitive Scenario
    • 7.10.3.3. Regulatory framework
    • 7.10.3.4. Reimbursement scenario
    • 7.10.3.5. UAE market estimates and forecasts, 2018-2030
  • 7.10.4. Kuwait
    • 7.10.4.1. Key country dynamics
    • 7.10.4.2. Competitive Scenario
    • 7.10.4.3. Regulatory framework
    • 7.10.4.4. Reimbursement scenario
    • 7.10.4.5. Kuwait market estimates and forecasts, 2018-2030

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2022
  • 8.3.4. Medtronic
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. 3M
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Smith & Nephew PLC
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Molnlycke Health Care AB
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Ethicon Inc. (JOHNSON & JOHNSON)
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Beiersdorf AG
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Urgo Medical
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. B. Braun Melsungen AG
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Dynarex Corporation
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives
  • 8.3.13. Winner Medical Group, Inc.
    • 8.3.13.1. Company overview
    • 8.3.13.2. Financial performance
    • 8.3.13.3. Product benchmarking
    • 8.3.13.4. Strategic initiatives
  • 8.3.14. McKesson Corporation
    • 8.3.14.1. Company overview
    • 8.3.14.2. Financial performance
    • 8.3.14.3. Product benchmarking
    • 8.3.14.4. Strategic initiatives
  • 8.3.15. Cardinal Health
    • 8.3.15.1. Company overview
    • 8.3.15.2. Financial performance
    • 8.3.15.3. Product benchmarking
    • 8.3.15.4. Strategic initiatives
  • 8.3.16. 3L Medicinal Products Group
    • 8.3.16.1. Company overview
    • 8.3.16.2. Financial performance
    • 8.3.16.3. Product benchmarking
    • 8.3.16.4. Strategic initiatives
  • 8.3.17. Paul Hartmann AG
    • 8.3.17.1. Company overview
    • 8.3.17.2. Financial performance
    • 8.3.17.3. Product benchmarking
    • 8.3.17.4. Strategic initiatives